Sierra Sacramento Valley EMS Agency

Similar documents
Overdose Response Training

Naloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no

Naloxone Intranasal Administration in the Pre-hospital Setting Basic Life Support (BLS) Pilot Program

The Solution. A multi-faceted approach to overdose prevention is required. A comprehensive array of efforts are underway in Oklahoma, including:

SAN JOAQUIN COUNTY EMERGENCY MEDICAL SERVICES AGENCY. Administration of Naloxone for Opiate Overdose

Application Naloxone by BLS Providers within a Respective EMS Agency

Naloxone Standing Order for Opioid Overdose

COMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, Objectives: Key Terms

Transcript for Overdose Responder Training: Adapted from NJ Department of Human Services/Division of Mental Health and Addiction Services

Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off.

PROJECT TEAM. Karen Tilashalski, Alison Donoho, Marianne Drainer,

NASSAU REGIONAL EMERGENCY MEDICAL ADVISORY COMMITTEE

Fentanyl Fact and Fiction: The Rise of America s Narcotic Crisis. Dan

Naloxone Intranasal EMT OPTIONAL SKILL. Cell Phones and Pagers. Course Outline 09/2017

Calvert County Health Department Overdose Education and Naloxone Training

Harm Reduction Coalition DOPE Project Eliza Wheeler 1440 Broadway Suite 902 Oakland, CA

Revised 16 February, of 7

Otterbein Police Department. Opioid Addition Awareness

Naloxone Opioid Rescue Kits. Aaron Kochar, JD

Opioids - Fentanyl - Naloxone. Public Health Nurse

Pennsylvania DEPARTMENT OF HEALTH

Administration of Naloxone for Opiate Overdose Minutes

Opioids and Overdose 2017

Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative

NALOXONE (NARCAN) POLICY

Pharmacist Learning Objectives

Naloxone Opioid Overdose Reversal Collaborative Drug Therapy Agreement

Naloxone in Schools. Training for School Staff

MODUS OPERANDI FENTANYL. Control No.: P-693/

Opioid Overdose Prevention for Law Enforcement and First Responders. Sponsored by the NC Office of EMS

Take Home Naloxone elearning Module Script

FENTANYL AND CARFENTANIL EXPOSURE IN PARAMEDIC SERVICES

Campus Narcan Project OPIOID OVERDOSE FIRST RESPONDER TRAINING

PL CE LIVE: Overdose Prevention with Naloxone Opportunities for Pharmacists May 2015

First Responder Naloxone Grant Webinar

Law Enforcement Naloxone Training Florida Department of Children and Families. Office of Substance Abuse and Mental Health

Opioid Overdose Education and Naloxone Distribution

Opiate Overdose Treatment: Naloxone Training Protocol

Opioid Harm Reduction

ADMINISTRATIVE REQUIREMENT MANUAL EFFECTIVE DATE

Drug Class Review: Opioid Reversal Agents

Naloxone Statewide Standing Order. Cheryl A. Viracola, PharmD Pharmacy Programs Manager, Community Care of Wake and Johnston Counties

Substance Misuse and Abuse

Skills and Knowledge on Overdose Prevention. Bill Matthews, RPA-C Bethany Medley, MSW Bruce Trigg, MD

Pharmacist Directed Opioid Antagonist Dispensing

OVERDOSE IN UTAH PREVENTION AND RESPONSE. Meghan Balough, MPH Heather Bush, B.S. Suicide Conference October 6, 2017

COUNTY OF SACRAMENTO EMERGENCY MEDICAL SERVICES AGENCY

Braintree Public Schools

NALOXONE RISK ASSESSMENT

Naloxone Non-Patient Specific Prescription and Pharmacist Dispensing Protocol, New York City

BROCKTON AREA S OPIOID OVERDOSE PREVENTION TRAINING

Role of the Pharmacist: Naloxone Training. Kathleen Besinque, Pharm.D.,MSEd., FASHP, FCPhA Loma Linda University School of Pharmacy

The Opioid Crisis URBAN FIRE FORUM SEPTEMBER 20-22, 2017

Vermont's Opioid Crisis and Response to the Crisis

ORC Why Narcan? Things to know about Narcan. Things to know about Narcan 4/16/2018

Fentanyls and Naloxone. Opioids, Overdose, and Naloxone

NARCAN? YOU CAN!: A LEGISLATIVE & CLINICAL UPDATE ON NALOXONE

A Conversation on Fentanyl. School District 22 VERNON

THE OPIATE EPIDEMIC AND LIBRARIES. Presented by Dr. Steve Albrecht, PHR, CPP, BCC, CTM

The Missouri Opioid-Heroin Overdose Prevention and Education (MO-HOPE) Project Mission: to reduce opioid overdose deaths in Missouri through expanded

Opioid Overdose: Risks, Clinical Features, Treatment, and Reduction of Negative Consequences

WR Fentanyl Symposium. Opioids, Overdose, and Fentanyls

3/19/18. Background. School Substance Use Problem: Naloxone and How It Will Be Implemented in Schools. Background

Powell Recovery Center

Welcome to the Opioid Overdose Prevention Project

Officer Al Fear Eastern Iowa Heroin Initiative Cedar Rapids Police Department U.S. Attorney s Office NDIA

Administrating Medications with the MAD Device

Intranasal Administration of Naloxone by the EMT-Basic FDNY Proposal for a New York State Demonstration Project

PREVENTING OPIATE OVERDOSES IN SCHOOLS. Head 2 Toe 2017 April 20, 2017 Winona Stoltzfus BSN, MD, School Health Officer and Acting RHO SE Region

Prescription Opioids

Protocol For: Personally Furnishing Naloxone. Update Log

DISPENSING OR SELLING NALOXONE. Guidance for pharmacy professionals when dispensing or selling naloxone as a Schedule II drug.

HEALTHCARE AND THE OPIOID EPIDEMIC DAN MUSE, MD SIGNATURE HEALTHCARE-BROCKTON HOSPITAL

How to Prevent an Opioid Overdose

Naloxone for Emergency Administration: A 2017 Update On FDA Guidance

LifeWays Operating Procedure

Heroin What You Need to Know

Naloxone. Medical Uses. Opiate overdose. From Wikipedia, the free encyclopedia. Naloxone

3/26/14. Opiates PSY B396 ALCOHOL, ALCOHOLISM, & DRUG ABUSE. Early History Cont d. Early History. Opiate Use in the 19th century. Technology Advances

Take Home Naloxone: Law Update and Considerations for Pharmacy Professionals

Massachusetts Department of Public Health Opioid Overdose Education and Naloxone Distribution. MDPH Naloxone pilot project Core Competencies

Naloxone and Combating the Opioid Epidemic

Overdose Crisis: A harm reduction approach

OVERDOSE PREVENTION AND EDUCATION OVERDOSE MANAGEMENT

Sierra Sacramento Valley EMS Agency Policy/Protocol Manual Table of Contents

Naloxone: Preventing Opioid Overdose in the Community. Sharon Stancliff, MD Medical Director Harm Reduction Coalition

OSF NORTHERN REGION EMERGENCY MEDICAL SERVICES STANDING MEDICAL ORDERS ILS, ALS. SMO: Adult Pain Management

PROTECTING FIRST RESPONDERS FROM EXPOSURE TO FENTANYL

A Bill Regular Session, 2015 SENATE BILL 880

What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls?

Substance Misuse and Abuse

NARCAN: THE HISTORY, APPLICATIONS AND FUTURE

NALOXONE LEARNING ABOUT NALOXONE COULD SAVE A LIFE

Chapter 7, Medication Administration Part 1 Principles and Routes of Medication Administration Caution: Administering medications is business Always

DHEC Bureau of EMS DAODAS

Sierra Sacramento Valley EMS Agency

Presentation at National Academies of Sciences Engineering Medicine

Overdose Prevention, Recognition & Response Education Train-the-Trainer

NALOXONE AND OVERDOSE PREVENTION EDUCATION PROGRAM OF RHODE ISLAND

Transcription:

Sierra Sacramento Valley EMS Agency BLS IN NALOXONE ADMINISTRATION OPTIONAL SKILL (UPDATED 06/2017) Acknowledgement: Siskiyou County SO - source of some slide content

In order for PSFA, EMR or EMT personnel to administer IN naloxone, they must: Be part of the organized EMS system, functioning under the oversight of an S-SV EMS approved BLS optional skills provider Be authorized by the approved BLS optional skills provider to administer IN naloxone Have received adequate training on IN naloxone administration

Education/Training Purpose and Objectives Purpose o To enable authorized PSFA, EMR and EMT personnel to administer IN naloxone to patients in the prehospital setting Objectives o Review background and causes of opioid overdoses o Identify signs and symptoms of an opioid overdose o Understand naloxone actions, indications, contraindications, dose, route, warnings and potential adverse reactions o Understand intranasal medication delivery o Describe/demonstrate treatment for suspected opioid overdose

Opioid Overdose Background & Causes Identification of an Opioid Overdose Naloxone Information Intranasal (IN) Medication Administration

Opioid Overdose Background & Causes About opioids o Sedative narcotics Used primarily in medicine for pain relief Induce euphoria users feel warm, drowsy and content Depressants high levels can suppress the urge to breathe Street opioids include heroin, street fentanyl, M-18, etc. Prescription opioids included Hydrocodone/Norco, Oxycodone, morphine, fentanyl, etc. Type, strength and consumption method influences to what degree and how long their effects last

Opioid Overdose Background & Causes About opioids (cont.) o Other opioids of concern Street fentanyl ( disguised as Norco) M-18 Synthetic opioid 100 times more potent than fentanyl 10,000 times more potent than morphine Street fentanyl M-18

Opioid Overdose Background & Causes About opioids (cont.) o Other opioids of concern Carfentanil (elephant tranquilizer) Analogue of fentanyl 100 times more potent than fentanyl 10,000 times more potent than morphine

Opioid Overdose Background & Causes Opioid abuse is a major public health epidemic o 16,325 prescription opioid-related deaths in the US in 2013 (4x the number of deaths that occurred in 1999) o 8,257 deaths in the US from heroin in 2013 o 7,428 prescription opioid-related deaths in California from 2008 to 2012 (16.5% increase from 2006) o 1,800 opioid-related deaths in California in 2012 alone (72% involved prescription pain medications)

Opioid Overdose Background & Causes Efforts undertaken to combat the crisis o Calls to improve opioid prescription practices o Greater access to addiction treatment o Public naloxone distribution programs 2015 California State Board of Pharmacy emergency regulations allow pharmacists to dispense naloxone without a prescription o Increased utilization of naloxone by BLS first responders

Opioid Overdose Background & Causes About the solution o Abstinence from illegal drug use is the most effective overdose prevention tool Most users attempt to achieve abstinence - on average this process takes 9 years/4 episodes of care to achieve success o Naloxone administration: Temporarily reverses the effects of opioids Only given when the patient is unresponsive and breathing ineffectively or not at all Safe and effective has no effect on non-opioid overdoses

Opioid Overdose Identification Recognize overdose symptoms Recognize the drug Recognize drug paraphernalia Recognition of need for naloxone administration Look for physical signs and symptoms of overdose as well as drug paraphernalia and/or pill bottles If in doubt or uncertain and patient is unresponsive with respiratory depression consider naloxone administration

Opioid Overdose Identification REALLY HIGH (NALOXONE NOT INDICATED) OVERDOSE (ADMINISTER NALOXONE) Muscles become relaxed Deep snoring or gurgling (death rattle) Speech is slowed/slurred Infrequent (less than 12 breaths per minute) or not breathing Sleepy looking Pale, clammy skin Nodding Heavy nod Will respond to stimulation like yelling, sternal rub, pinching, etc. No response to stimulation

Naloxone Information Naloxone actions o Temporarily blocks the effects of opioids resulting in improved respiratory and neurological status Naloxone onset and duration o Works in 1 3 minutes o Lasts up to 30 60 minutes Naloxone contraindications o Known hypersensitivity (rare)

Naloxone Information Naloxone warnings o May induce opioid withdrawal in patients who are physically dependent o Certain drugs may require much higher naloxone doses Naloxone potential adverse reactions o Rapid or irregular heart rate o High blood pressure o Nausea/vomiting o Diaphoresis (sweating)

Intranasal (IN) Medication Administration IN administration o Uncomplicated and convenient o The nose is an easy access point for medication delivery o Painless, no shots required o Eliminates any risk of needle stick

Intranasal (IN) Medication Administration IN administration (cont.) o The smelling area in the nose (olfactory mucosa) is in direct contact with the brain and CSF o Medications absorbed across the olfactory mucosa directly enter the CSF and provide a rapid/direct route for drug delivery to the brain Olfactory mucosa Nerve CSF Brain Highly Vascular Nasal Mucosa

Intranasal (IN) Medication Administration IN administration (cont.) o Bioavailability = how much medication ends up in the blood stream Intravenous (IV) medications have 100% bioavailability Oral medications are have 5% - 10% bioavailability due to destruction in the gut and liver Intranasal (IN) medications vary, but IN naloxone approaches 100% bioavailability (same as when given IV) Naloxone IV and IN administration serum levels are identical after about 2 3 minutes

Intranasal (IN) Medication Administration IN administration (cont.) o If there is something wrong with the nasal mucosa, it may not absorb IN administered medications effectively examples: Vasoconstrictors, such as cocaine, prevent medication absorption Bloody nose, nasal congestion and/or mucous discharge may prevent medication absorption Destruction of nasal mucosa (surgery, past cocaine abuse, etc.) results in no mucosa to absorb the medication

Treatment Of Suspected Opioid Overdose

Treatment Of Suspected Opioid Overdose Ensure appropriate EMS units have been requested Ensure scene safety o Utilize appropriate personal protective equipment (PPE) o Be aware of potential hazards Needles Hazardous materials Bystanders, nearby traffic, etc.

Treatment Of Suspected Opioid Overdose Assess patient o Stimulate shake and shout o If pulseless, begin chest compressions o Assess/support respiratory status o Administer high flow O 2 (if available) o If no response to stimulation and continued poor/absent breathing, administer intranasal (IN) naloxone

Treatment Of Suspected Opioid Overdose Naloxone 2 mg preloaded syringe with mucosal atomizer device (MAD) o Administer ½ dose in each nostril when patient exhales and before inhalation

Treatment Of Suspected Opioid Overdose NARCAN Nasal Spray 4 mg o If using this type, all medication can be administered in one nostril o Administer when patient exhales and before inhalation

Treatment Of Suspected Opioid Overdose Additional treatment notes: o Observe for improved breathing/consciousness, if no improvement assist breathing with BVM (if available) or begin CPR if appropriate o If CPR is not necessary and it is possible, place patient in recovery position to avoid potential for inhaling any vomit o Consider additional doses of naloxone if necessary and available

Treatment Of Suspected Opioid Overdose Additional treatment notes (cont.) o Use naloxone with caution in patients with significant trauma who have not been adequately immobilized Consider the concurrent need for appropriate immobilization/spinal motion restriction o Although rare, be alert for sudden agitated/violent behavior o Because naloxone stops the effects of opioids, an opioid dependent person may experience acute withdrawal symptoms

Treatment Of Suspected Opioid Overdose Other responsibilities o Inform other appropriate EMS providers and/or the receiving hospital of any pertinent details related to the naloxone administration o Adequately document the naloxone administration for reporting and QI review requirements

Treatment Of Suspected Opioid Overdose Keep in mind o Naloxone is only for unconscious patients breathing ineffectively or not at all Do not use prophylactically or for individuals who are simply under the influence without respiratory depression o Naloxone only treats the effects of opioids If no opioids are present, there is no effect from administering naloxone Naloxone will not treat the effects of alcohol, cocaine, or other substances